semaglutide night sweats Sweats: Menopause, Other Causes & Treatment Night Sweats Causes and Treatment

Semaglutide is not currently approved for the treatment of type 1 diabetes, and its safety and efficacy in this population have not been established

The medication still works the same way as natural GLP-1 at its target receptors

[DOI] [PubMed] [Google Scholar] 33.Eickhoff H., Rodrigues T., Neves I., Marques D., Ribeiro D., Costa S., Seia R., Matafome P

Canada GLP-1 Receptor Agonist Market Analysis The GLP-1 receptor agonist market in Canada was valued at USD 4.35 billion in 2025, supported by increasing prevalence of obesity and type 2 diabetes, expanding access to innovative diabetes therapies, and growing emphasis on chronic disease management

Some limited research has observed modest changes in cortisol patterns in patients treated with GLP-1 receptor agonists, but these effects appear to be secondary consequences of metabolic improvement rather than direct pharmacological actions on cortisol production